OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673,263 | -39.1% | 214,415 | 0.0% | 0.00% | – |
| Q2 2023 | $1,106,381 | +1.8% | 214,415 | +4.0% | 0.00% | – |
| Q1 2023 | $1,086,932 | +89.1% | 206,249 | +0.8% | 0.00% | – |
| Q4 2022 | $574,726 | -31.1% | 204,529 | +1.9% | 0.00% | – |
| Q3 2022 | $834,000 | +3.5% | 200,787 | +0.2% | 0.00% | – |
| Q2 2022 | $806,000 | -19.1% | 200,369 | -0.3% | 0.00% | – |
| Q1 2022 | $996,000 | -26.0% | 201,067 | +4.1% | 0.00% | – |
| Q4 2021 | $1,346,000 | -46.4% | 193,093 | -23.0% | 0.00% | -100.0% |
| Q3 2021 | $2,509,000 | -29.1% | 250,841 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $3,537,000 | -11.1% | 249,425 | +2.9% | 0.00% | 0.0% |
| Q1 2021 | $3,977,000 | +13.9% | 242,297 | +43.7% | 0.00% | 0.0% |
| Q4 2020 | $3,491,000 | +210.9% | 168,640 | +14.3% | 0.00% | 0.0% |
| Q3 2020 | $1,123,000 | +1.7% | 147,490 | +11.4% | 0.00% | 0.0% |
| Q2 2020 | $1,104,000 | +101.5% | 132,447 | +19.7% | 0.00% | – |
| Q1 2020 | $548,000 | +20.7% | 110,622 | -3.6% | 0.00% | – |
| Q4 2019 | $454,000 | +36.7% | 114,755 | +5.2% | 0.00% | – |
| Q3 2019 | $332,000 | -25.1% | 109,035 | +8.3% | 0.00% | – |
| Q2 2019 | $443,000 | +52.2% | 100,658 | +37.7% | 0.00% | – |
| Q1 2019 | $291,000 | +0.7% | 73,073 | +0.7% | 0.00% | – |
| Q4 2018 | $289,000 | -42.2% | 72,559 | 0.0% | 0.00% | – |
| Q3 2018 | $500,000 | +2.0% | 72,559 | 0.0% | 0.00% | – |
| Q2 2018 | $490,000 | +40.4% | 72,559 | +35.4% | 0.00% | – |
| Q1 2018 | $349,000 | +102.9% | 53,570 | +39.3% | 0.00% | – |
| Q4 2017 | $172,000 | -27.7% | 38,470 | 0.0% | 0.00% | – |
| Q3 2017 | $238,000 | -33.3% | 38,470 | 0.0% | 0.00% | – |
| Q2 2017 | $357,000 | -0.3% | 38,470 | 0.0% | 0.00% | – |
| Q1 2017 | $358,000 | +11.2% | 38,470 | 0.0% | 0.00% | – |
| Q4 2016 | $322,000 | +151.6% | 38,470 | +107.2% | 0.00% | – |
| Q3 2016 | $128,000 | +39.1% | 18,570 | 0.0% | 0.00% | – |
| Q2 2016 | $92,000 | -48.9% | 18,570 | 0.0% | 0.00% | – |
| Q1 2016 | $180,000 | +2.9% | 18,570 | 0.0% | 0.00% | – |
| Q4 2015 | $175,000 | -33.2% | 18,570 | 0.0% | 0.00% | – |
| Q3 2015 | $262,000 | -33.0% | 18,570 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $391,000 | +12.0% | 18,570 | +123.7% | 0.00% | – |
| Q1 2015 | $349,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |